RSS Feed Content – New on the website

07.05.2021

Vaccine for children aged 12 to 15: Pfizer submits authorisation application to Swissmedic

The vaccine "Comirnaty®" is currently authorised for people aged 16 and over. The application asks for the authorisation to be extended to include the age group of 12-15-year-olds.

07.05.2021

Side effects of COVID-19 vaccines in Switzerland – update

1953 reports of suspected adverse reactions to COVID-19 vaccines in Switzerland evaluated

06.05.2021

Market surveillance of COVID-19 vaccines: reporting suspected side effects correctly

Reporting ADRs: important information for healthcare professionals and vaccinated individuals

06.05.2021

Praktikum

Job advertisement | Abteilung Medical Devices Clinical Investigations

05.05.2021

Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

05.05.2021

Swissmedic Journal

Latest edition
Swissmedic Journal April 2021

04.05.2021

International trade with wholesalers outside the EU

Licence holders required to check suppliers more rigorously

04.05.2021

HPC – Micotil 300 ad us. vet.

Neue Wartezeit für essbares Gewebe: 70 Tage

30.04.2021

Inspektor*in 80 - 100%

Job advertisement | Einheit Inspektorate

22.04.2021

Side effects of COVID-19 vaccines in Switzerland – update

1485 reports of suspected adverse reactions to COVID-19 vaccines in Switzerland evaluated

21.04.2021

Questions on delimitation

MU100_00_003d_MB Produkte mit Cannabidiol (CBD) – Überblick und Vollzugshilfe - German version revised; English version will follow

20.04.2021

COVID-19 medicine from Roche Pharma (Switzerland) AG can be used in Switzerland

The active substances in "RegN-Cov 2", the COVID-19 medicinal product from Roche Pharma (Switzerland) AG, are now covered by the COVID-19 Ordinance 3 and may be placed on the market following the submission of an authorisation application to Swissmedic.

19.04.2021

Assistent/in 80 %

Job advertisement | Abteilung Marktkontrolle Arzneimittel

16.04.2021

Potential nitrosamine contamination

Update – April 2021

14.04.2021

«Visible» Nr. 3/April 2021

Independence, humanity, strength & integration: those are values we focus on in the 3rd issue of the Swissmedic magazine ‘Visible’. Enjoy the read!

13.04.2021

Important information for pharmaceutical companies regarding electronic pharmacovigilance reporting

From 1 July 2021 only electronic reports will be accepted

12.04.2021

Clinical Reviewer Risk Management 80 – 100 %

Job advertisement | Abteilung Arzneimittelsicherheit

09.04.2021

Side effects of COVID-19 vaccines in Switzerland – update

1174 reports of suspected adverse reactions to COVID-19 vaccines in Switzerland evaluated

Last modification 01.12.2017

Top of page